PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsStem cell treatment for Duchenne muscular dystrophy tested in dogs

BioNews

Stem cell treatment for Duchenne muscular dystrophy tested in dogs

Published 9 June 2009 posted in News and appears in BioNews 385

Author

Heidi Nicholl

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).

A team of scientists based in France and Italy have published work showing a huge improvement in the condition of dogs suffering from a canine version of muscular dystrophy when treated with adult stem cells. Duchenne muscular dystrophy is a serious disease that affects 1 in every...

A team of scientists based in France and Italy have published work showing a huge improvement in the condition of dogs suffering from a canine version of muscular dystrophy when treated with adult stem cells. Duchenne muscular dystrophy is a serious disease that affects 1 in every 3500 male births. The illness is caused by a gene mutation in a protein called dystrophin - resulting in complete absence of the protein - which plays a crucial role in maintaining muscles. The disease first appears at around three to five years of age with progressive muscle wasting and eventual paralysis, until premature death, usually in the twenties, through weakness in the heart and lung muscles.


The researchers were following up successful work on mice which used stem cells to replace the missing protein in animals modified to lack dystrophin. As mice missing the dystrophin protein do not develop the disease the team next turned to dogs who do develop a form of the disease very similar to Duchenne muscular dystrophy in humans. The team used two approaches, one used cells transplanted from healthy dogs in combination with immune suppressing drugs to prevent rejection and the second approach used muscle precursor cells from the sick dogs modified to express the missing protein. In the first approach using healthy dogs, the researchers took cells called mesoangioblasts from small blood vessels in muscle. Mesoangioblasts are a type of blood stem cell programmed to develop into muscle. The cells were then grown in the laboratory until there were sufficient numbers to use in injections on the sick animals. Five monthly injections of tens of millions of the healthy cells were given to the dogs suffering from the illness, the cells were then carried around the body where they integrated into affected muscles improving their strength.


In the second approach the team again removed mesoangioblasts from the blood vessels in the muscles, but this time from animals suffering from the muscular dystrophy-like illness. They then used genetic modification techniques to correct the faulty copy of the dystrophin gene, again growing the cells in the laboratory to gain sufficient numbers. The modified cells were then injected back into the sick animals, but no improvement was found, even though the gene therapy seemed to work at a molecular level. For the dogs treated using donated healthy cells the improvement was notable - affected animals usually develop walking problems by 8 months of age, after stem cell treatment some of the animals were still walking well at 13 months old. The scientists are optimistic about being able to improve the approach using a modified version of the sufferer's own cells by using a different version of the dystrophin gene. Using a modified version of the sufferer's own cells is very desirable as it would avoid a lifetime of anti-rejection drugs. The dystrophin gene is notoriously difficult to work with as it is the largest gene in the human genome at two and a half million base pairs long.


The work was carried out at the San Raffaele Scientific Institute in Milan, Italy, in collaboration with the University of Pavia and the Veterinarian School of Macon Alfort in Paris. Lead researcher Professor Giulio Cossu hopes to begin trials in humans in the next few years, probably first utilising the approach that worked best in dogs - stem cells from tissue matched donors. He commented, 'Even though by itself it may not lead to a complete cure, it would ameliorate the condition, then step by step we could work on this to the point of getting a real cure.' The research is published in the journal Nature.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 November 2012 • 2 minutes read

Muscular dystrophy screening should be NHS priority, says expert

by Sarah Pritchard

The NHS must be prepared to screen every newborn baby for Duchenne muscular dystrophy (DMD) — the most severe form of muscular dystrophy — in three years time, says a leading UK geneticist who explains that promising treatments are close to becoming a reality...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 2 minutes read

Stem cell breakthrough gives hope to those affected by muscle wasting diseases

by Rosie Beauchamp

It was reported this week in the journal Stem Cell that a group of researchers from the University of New South Wales, Australia, have made a major breakthrough in the success of regrowing damaged muscle tissue using adult stem cells. Previous research carried out at the University...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Stem cell therapy treats muscular dystrophy in mice

by Dr Rebecca Robey

Researchers at the University of Texas Southwestern Medical Centre have developed a new technique to treat the symptoms of muscular dystrophy using embryonic stem (ES) cells. The group, reporting in the February 2008 issue of Nature Medicine, successfully manipulated mouse ES cells to transform them into muscle-forming...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 1 minute read

Treatment hope for childhood muscle wasting disorder

by Ailsa Stevens

The first trial of a new treatment for Duchenne muscular dystrophy (DMD) will start later this year in the UK. The treatment, which has been developed by using human cells and mice experiments, hopes to overcome the effects of the genetic defect that causes the muscle wasting...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Parkinson's stem cell research produces mixed results

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

4 July 2022 • 2 minutes read

Genetic variant increases Alzheimer's risk, especially in women

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856